C-Reactive Protein as a Cardiovascular Risk Factor
- 6 July 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 100 (1) , 96-102
- https://doi.org/10.1161/01.cir.100.1.96
Abstract
Background—Circulating levels of C-reactive protein (CRP) may constitute an independent risk factor for cardiovascular disease. How CRP as a risk factor is involved in cardiovascular disease is still unclear. Methods and Results—By reviewing available studies, we discuss explanations for the associations between CRP and cardiovascular disease. CRP levels within the upper quartile/quintile of the normal range constitute an increased risk for cardiovascular events, both in apparently healthy persons and in persons with preexisting angina pectoris. High CRP responses after acute myocardial infarction indicate an unfavorable outcome, even after correction for other risk factors. This link between CRP and cardiovascular disease has been considered to reflect the response of the body to the inflammatory reactions in the atherosclerotic (coronary) vessels and adjacent myocardium. However, because CRP localizes in infarcted myocardium (with colocalization of activated complement), we hypothesize that CRP may directly interact with atherosclerotic vessels or ischemic myocardium by activation of the complement system, thereby promoting inflammation and thrombosis. Conclusions—CRP constitutes an independent cardiovascular risk factor. Unraveling the molecular background of this association may provide new directions for prevention of cardiovascular events.Keywords
This publication has 67 references indexed in Scilit:
- A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cellsImmunology Today, 1997
- C-reactive protein as a predictor of cardiac rupture after acute myocardial infarctionAmerican Heart Journal, 1996
- Episodic activation off the coagulation system in unstable angina does not elicit an acute phase reactionThe American Journal of Cardiology, 1996
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Immune and inflammatory mechanisms in the development of atherosclerosisHeart, 1993
- Acute Phase Reaction, Infarct Size and In-Hospital Morbidity in Myocardial Infarction Patients Treated With Streptokinase or Recombinant Tissue Type Plasminogen ActivatorAnnals of Medicine, 1991
- Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardiumClinical and Experimental Immunology, 1990
- Elevation of C-reactive protein in “active” coronary artery diseaseThe American Journal of Cardiology, 1990
- The complement system in atherosclerosisAtherosclerosis, 1988
- STUDIES OF ACUTE-PHASE PROTEIN. II. LOCALIZATION OF Cx-REACTIVE PROTEIN IN HEART IN INDUCED MYOCARDIAL INFARCTION IN RABBITS*Journal of Clinical Investigation, 1963